Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BVS

Bioventus Inc

Dec 11 • 04:00PM ET

7.42

-0.08 -1.07 %

Healthcare • Medical Devices • USA • NASD

Peers: ZBH SNN GMED IART XRAY OFIX BAX CNMD PODD MEDP

| Held by: IWM VTI AVUV VXF IWO FESM SCHA VTWO DFAS IWC

Scroll to Statements

Index	RUT	P/E	66.07	EPS (ttm)	0.11	Insider Own	31.30%	Shs Outstand	66.97M	Perf Week	-2.62%
Market Cap	614.10M	Forward P/E	10.31	EPS next Y	0.72	Insider Trans	-0.11%	Shs Float	46.04M	Perf Month	-3.64%
Enterprise Value	954.27M	PEG	0.46	EPS next Q	0.20	Inst Own	54.17%	Short Float	3.92%	Perf Quarter	2.63%
Income	7.82M	P/S	1.09	EPS this Y	9.14%	Inst Trans	0.36%	Short Ratio	5.80	Perf Half Y	10.58%
Sales	563.83M	P/B	2.99	EPS next Y	34.61%	ROA	1.06%	Short Interest	1.81M	Perf YTD	-29.33%
Book/sh	2.48	P/C	14.57	EPS next 5Y	22.47%	ROE	4.97%	52W High	11.75 -36.85%	Perf Year	-33.15%
Cash/sh	0.51	P/FCF	11.48	EPS past 3/5Y	- -113.92%	ROIC	1.59%	52W Low	5.81 27.71%	Perf 3Y	237.27%
Dividend Est.	-	EV/EBITDA	9.97	Sales past 3/5Y	9.98% 11.00%	Gross Margin	66.66%	Volatility	4.79% 5.00%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.69	EPS Y/Y TTM	118.96%	Oper. Margin	8.51%	ATR (14)	0.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.14	Sales Y/Y TTM	1.58%	Profit Margin	1.39%	RSI (14)	52.60	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.74	EPS Q/Q	161.98%	SMA20	1.20%	Beta	0.79	Target Price	15.00
Payout	-	Debt/Eq	2.05	Sales Q/Q	-0.23%	SMA50	4.35%	Rel Volume	0.75	Prev Close	7.50
Employees	930	LT Debt/Eq	1.96	Earnings	Nov 04 BMO	SMA200	1.09%	Avg Volume	311.43K	Price	7.42
IPO	Feb 11, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	43.27% 0.34%	Trades		Volume	353,251	Change	-1.07%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-07-25	Initiated	Cantor Fitzgerald	Overweight	$12
Dec-17-24	Upgrade	JP Morgan	Underweight → Neutral	$12 → $13
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy	$7
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy	$4 → $6
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold	$18 → $6
Mar-15-22	Initiated	Craig Hallum	Buy	$30
Nov-15-21	Resumed	Morgan Stanley	Overweight	$20
Nov-10-21	Resumed	JP Morgan	Overweight	$25
Jul-01-21	Downgrade	Goldman	Buy → Neutral	$20 → $19
Mar-08-21	Initiated	Morgan Stanley	Overweight	$18
Mar-08-21	Initiated	JP Morgan	Overweight	$17
Mar-08-21	Initiated	Goldman	Buy	$19
Mar-08-21	Initiated	Canaccord Genuity	Buy	$23

Show Previous Ratings

Dec-05-25 03:30PM	HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire) -6.96%
Nov-25-25 04:15PM	Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) +5.13%
Nov-04-25 04:08PM	Bioventus Inc (BVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com) +15.09%
07:44AM	Bioventus: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Reports Third Quarter Financial Results (GlobeNewswire)
08:02AM	Loading…
Nov-03-25 08:02AM	What To Expect From Bioventus Inc (BVS) Q3 2025 Earnings (GuruFocus.com)
Oct-28-25 07:00AM	Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 (GlobeNewswire)
Oct-22-25 07:08PM	Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Sep-03-25 07:30AM	Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire)
Aug-13-25 12:08PM	Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT (Insider Monkey)
Aug-07-25 04:15PM	Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference (GlobeNewswire)
Aug-06-25 08:55AM	Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates (Zacks) +18.73%
07:52AM	Bioventus: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Bioventus Reports Second Quarter Financial Results (GlobeNewswire)
Aug-05-25 10:18AM	What To Expect From Bioventus Inc (BVS) Q2 2025 Earnings (GuruFocus.com)
08:00AM	Loading…
Aug-04-25 08:00AM	Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity (GlobeNewswire)
Jul-30-25 07:30AM	Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products (GlobeNewswire)
Jul-29-25 04:15PM	Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jul-16-25 09:39AM	Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating (Insider Monkey)
Jun-13-25 08:30AM	Do Options Traders Know Something About Bioventus Stock We Don't? (Zacks)
May-07-25 03:09AM	Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures (GuruFocus.com) +6.29%
01:21AM	Q1 2025 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents)
May-06-25 08:45AM	Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates (Zacks) -11.81%
07:50AM	Bioventus: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Reports First Quarter Financial Results (GlobeNewswire)
May-05-25 10:10AM	Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-28-25 08:00AM	Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-24-25 01:25AM	Artisan Sustainable Emerging Markets Fund Q1 2025 Commentary (Seeking Alpha)
Apr-17-25 08:21AM	4 Healthcare Stocks to Buy as the Sector Faces Government Heat (Zacks)
Apr-03-25 01:09PM	Ensign Group Invests in Growth With New Facility Acquisitions (Zacks)
09:55AM	Loading…
Mar-31-25 09:55AM	Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Mar-28-25 11:06AM	Centene & HMHB Hawaii Expand Partnership for Maternal Care (Zacks)
Mar-17-25 12:00PM	Bioventus (BVS) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-12-25 03:08AM	Q4 2024 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) -6.76%
03:04AM	Bioventus Inc (BVS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ... (GuruFocus.com)
Mar-11-25 08:45AM	Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates (Zacks) +23.29%
07:52AM	Bioventus: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-28-25 07:30AM	Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 (GlobeNewswire)
Jan-07-25 08:00AM	Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-03-25 08:05AM	Bioventus completes divestiture of its Advanced Rehabilitation business (TipRanks)
Jan-02-25 08:00AM	Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners (GlobeNewswire)
Dec-23-24 09:40AM	Is Bioventus (BVS) Outperforming Other Medical Stocks This Year? (Zacks)
Dec-06-24 09:55AM	Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet (Zacks)
Nov-06-24 02:43AM	Q3 2024 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents)
02:14AM	Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Nov-05-24 08:45AM	Bioventus (BVS) Matches Q3 Earnings Estimates (Zacks) -16.27%
07:41AM	Bioventus: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Reports Third Quarter Financial Results (GlobeNewswire)
Nov-04-24 09:40AM	Are Medical Stocks Lagging Bioventus (BVS) This Year? (Zacks)
07:09AM	Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-29-24 07:30AM	Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 (GlobeNewswire)
Oct-15-24 04:01PM	Solventum Stock Earns 81 RS Rating (Investor's Business Daily)
Oct-09-24 05:03PM	Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-01-24 09:00AM	Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners (GlobeNewswire)
Aug-29-24 07:09AM	Bull Of The Day: Bioventus (BVS) (Zacks)
Aug-07-24 04:15PM	Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference (GlobeNewswire) -7.79%
Aug-06-24 07:30AM	Bioventus Reports Second Quarter Financial Results (GlobeNewswire) +29.23%
Jul-30-24 07:30AM	Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024 (GlobeNewswire)
Jun-05-24 10:17AM	Here's Why You Should Consider Buying Bioventus (BVS) Stock (Zacks)
May-23-24 06:42AM	3 Stocks Under $10 With Mammoth Growth Prospects (InvestorPlace)
May-09-24 07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +8.33%
May-08-24 12:28PM	Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:19AM	Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ... (GuruFocus.com)
May-07-24 11:41PM	Q1 2024 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +28.00%
07:00AM	Bioventus Reports First Quarter Financial Results (GlobeNewswire)
Apr-29-24 07:30AM	Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024 (GlobeNewswire)
Mar-13-24 08:48AM	Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript (Insider Monkey) -5.54%
Mar-12-24 10:20PM	Q4 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +5.46%
09:11AM	Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ... (GuruFocus.com)
07:30AM	Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-04-24 08:00AM	Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024 (GlobeNewswire)
Jan-18-24 04:15PM	Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility (GlobeNewswire)
Jan-12-24 04:15PM	Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole (GlobeNewswire)
Dec-19-23 04:30PM	Bioventus Names Robert Claypoole as President and Chief Executive Officer (GlobeNewswire)
Dec-06-23 08:00AM	Bioventus Agrees to Nationwide Contract with Aetna Medicare Advantage Plans for DUROLANE for Knee Osteoarthritis (GlobeNewswire)
Nov-27-23 01:33AM	Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant (MedTech Dive)
Nov-12-23 09:02AM	Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 07:59AM	Bioventus Inc (BVS) Reports Q3 2023 Financial Results, Raises Full Year 2023 Financial Guidance (GuruFocus.com)
07:00AM	Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance (GlobeNewswire)
Oct-31-23 07:00AM	Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023 (GlobeNewswire) +5.37%
Oct-25-23 10:48AM	Bioventus (BVS) to Report Q3 Earnings: What's in the Cards? (Zacks)
Sep-28-23 07:43AM	3 Value Medical Stocks to Buy for Safety Amid Market Volatility (Zacks)
Sep-19-23 09:52PM	Bioventus to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-23 04:30PM	Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-16-23 09:02AM	Juniper Investment Company, LLC Increases Stake in Bioventus Inc (GuruFocus.com) -5.26%
Aug-10-23 08:09AM	Bioventus works to trim debt under interim CEO (American City Business Journals) +11.74%
Aug-08-23 10:02PM	Q2 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +14.12% +5.41%
07:30AM	Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance (GlobeNewswire)
Aug-04-23 08:30AM	Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference (GlobeNewswire)
Aug-01-23 05:35PM	Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jun-23-23 06:35PM	Madrigal Pharmaceuticals and Bioventus Stock See Action From Activist Investors (Barrons.com) -7.02%
May-25-23 06:38AM	Daily Vickers Top Buyers & Sellers for 05/25/2023 (Argus Research)
May-23-23 07:30AM	Bioventus Completes Divestiture of its Wound Business (GlobeNewswire) +16.27%
May-18-23 12:07PM	Bioventus Inc. (NASDAQ:BVS) Q1 2023 Earnings Call Transcript (Insider Monkey) +11.45%
May-17-23 08:33AM	Q1 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +9.17%
May-16-23 04:15PM	Bioventus Reports First Quarter Financial Results (GlobeNewswire)
May-15-23 05:33PM	Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023 (GlobeNewswire)
May-11-23 07:00AM	Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023 (GlobeNewswire) +17.48%
May-10-23 09:00AM	Bioventus Announces Divestiture of its Wound Business (GlobeNewswire) +6.95%

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NOHRA GUY P	Director	Dec 04 '25	Sale	7.57	10,000	75,658	116,610	Dec 08 05:02 PM
NOHRA GUY P	Director	Dec 04 '25	Proposed Sale	7.57	10,000	75,658		Dec 04 01:54 PM
McMurry-Heath Michelle	Director	Nov 07 '25	Sale	7.42	17,701	131,255	56,997	Nov 10 05:08 PM
McMurry-Heath Michelle	Director	Nov 07 '25	Proposed Sale	7.41	27,000	200,041		Nov 07 04:14 PM
Bartholdson John A.	Director	Jun 06 '25	Option Exercise	0.00	7,575	0	79,620	Jun 10 05:49 PM
Bartholdson John A.	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	72,045	Jun 05 09:22 AM
SUTTER MARTIN P	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	85,241	Jun 04 09:30 PM
STALNECKER SUSAN M	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	105,957	Jun 04 09:30 PM
NOHRA GUY P	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	126,610	Jun 04 09:30 PM
NEELS GUIDO J	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	85,241	Jun 04 09:30 PM
McMurry-Heath Michelle	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	74,698	Jun 04 09:30 PM
Ladone Mary Kay	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	78,981	Jun 04 09:30 PM
HAWKINS WILLIAM A	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	257,851	Jun 04 09:29 PM
Beyer Pat	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	76,436	Jun 04 09:29 PM
Singleton Mark Leonard	SVP & CFO	Apr 11 '25	Sale	7.57	3,875	29,334	141,088	Apr 15 05:50 PM
D'Adamio Anthony	SVP & General Counsel	Apr 11 '25	Sale	7.57	2,958	22,392	131,416	Apr 15 05:50 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Apr 11 '25	Sale	7.57	1,283	9,712	55,557	Apr 15 05:49 PM
D'Adamio Anthony	Officer	Apr 11 '25	Proposed Sale	9.51	4,000	38,040		Apr 11 05:39 PM
Singleton Mark Leonard	SVP & CFO	Apr 10 '25	Option Exercise	0.00	13,000	0	144,963	Apr 11 05:31 PM
D'Adamio Anthony	SVP & General Counsel	Apr 10 '25	Option Exercise	0.00	9,925	0	134,374	Apr 11 05:30 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Apr 10 '25	Option Exercise	0.00	4,300	0	56,840	Apr 11 05:30 PM
Singleton Mark Leonard	SVP & CFO	Mar 24 '25	Sale	9.79	5,479	53,639	131,963	Mar 25 05:37 PM
Singleton Mark Leonard	Officer	Mar 24 '25	Proposed Sale	9.80	12,000	117,600		Mar 24 04:50 PM
Singleton Mark Leonard	SVP & CFO	Mar 21 '25	Option Exercise	0.00	18,625	0	137,442	Mar 21 05:24 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Mar 17 '25	Sale	9.75	1,018	9,926	52,540	Mar 18 05:34 PM
D'Adamio Anthony	SVP & General Counsel	Mar 17 '25	Sale	9.75	2,615	25,496	124,449	Mar 18 05:33 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Mar 14 '25	Option Exercise	0.00	3,456	0	53,558	Mar 14 07:06 PM
D'Adamio Anthony	SVP & General Counsel	Mar 14 '25	Option Exercise	0.00	8,886	0	127,064	Mar 14 07:05 PM
Singleton Mark Leonard	SVP & CFO	Feb 18 '25	Sale	10.19	6,498	66,215	118,817	Feb 20 07:01 PM
D'Adamio Anthony	SVP & General Counsel	Feb 18 '25	Sale	10.19	4,380	44,632	118,178	Feb 20 07:00 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Feb 18 '25	Sale	10.19	1,537	15,662	50,102	Feb 20 07:00 PM
Singleton Mark Leonard	SVP & CFO	Feb 15 '25	Option Exercise	0.00	20,153	0	125,315	Feb 18 06:00 PM
D'Adamio Anthony	SVP & General Counsel	Feb 15 '25	Option Exercise	0.00	12,980	0	122,558	Feb 18 06:00 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Feb 15 '25	Option Exercise	0.00	4,375	0	51,639	Feb 18 05:59 PM
Claypoole Robert E	President and CEO	Jan 13 '25	Sale	9.10	28,786	261,953	64,964	Jan 14 06:59 PM
Claypoole Robert E	Officer	Jan 13 '25	Proposed Sale	9.55	33,000	315,150		Jan 13 09:16 PM
Claypoole Robert E	President and CEO	Jan 10 '25	Option Exercise	0.00	93,750	0	93,750	Jan 13 05:24 PM
Singleton Mark Leonard	SVP & CFO	Dec 23 '24	Sale	10.53	10,733	113,018	105,162	Dec 26 04:55 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Dec 23 '24	Sale	10.53	2,535	26,694	47,264	Dec 26 04:55 PM
D'Adamio Anthony	SVP & General Counsel	Dec 23 '24	Sale	10.53	5,848	61,579	109,578	Dec 26 04:54 PM
Singleton Mark Leonard	Officer	Dec 23 '24	Proposed Sale	11.15	19,000	211,850		Dec 23 05:37 PM
CHURCH KATRINA J	Officer	Dec 23 '24	Proposed Sale	11.15	8,000	89,200		Dec 23 05:35 PM
D'Adamio Anthony	Officer	Dec 23 '24	Proposed Sale	11.15	16,000	178,400		Dec 23 05:34 PM
Singleton Mark Leonard	SVP & CFO	Dec 20 '24	Option Exercise	0.00	31,000	0	115,895	Dec 23 05:28 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Dec 20 '24	Option Exercise	0.00	8,600	0	49,799	Dec 23 05:28 PM
D'Adamio Anthony	SVP & General Counsel	Dec 20 '24	Option Exercise	0.00	19,850	0	115,426	Dec 23 05:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BVS

Bioventus Inc

Upgrade your FINVIZ experience